Chemical Compound

N-((2R,3R,4R,5R,6R)-4,5-Dihydroxy-2-(((2R,3S,4S,5R,6S)-3-hydroxy-2-(hydroxymethyl)-6-(((2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl)oxy)-5-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-4-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide

CAS Registry Number 59957-92-5
返回搜索 申请报价
N-((2R,3R,4R,5R,6R)-4,5-Dihydroxy-2-(((2R,3S,4S,5R,6S)-3-hydroxy-2-(hydroxymethyl)-6-(((2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl)oxy)-5-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-4-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide 结构式
Primary record

N-((2R,3R,4R,5R,6R)-4,5-Dihydroxy-2-(((2R,3S,4S,5R,6S)-3-hydroxy-2-(hydroxymethyl)-6-(((2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl)oxy)-5-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-4-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide

库存
3,806 克
纯度
98.8 %
CAS
59957-92-5

化合物标识与属性

CAS
59957-92-5
PubChem CID
21252248
SMILES
C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@@H]2[C@H]([C@H]([C@H](O[C@H]2O[C@H]([C@@H](CO)O)[C@@H]([C@H](C=O)O)O)CO)O)O[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)NC(=O)C)O)O)O
Canonical SMILES
CC(=O)N[C@H]1[C@@H](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]([C@H](O)[C@@H](O)C=O)[C@H](O)CO)[C@@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)O[C@H](CO)[C@H](O)[C@@H]1O

名称与同义词

  • a-Tetrasaccharide
  • Alpha-Tetrasaccharide
  • RefChem:1075130
  • Blood group A tetrasaccharide
  • DTXSID601045128
  • orb1941914
  • SCHEMBL29396151
  • CHEBI:190838
  • DTXCID501527048
  • Blood group A antigen tetraose type 5
  • 59957-92-5
  • Blood Group A tetrasaccharide type V
  • HY-N10510
  • MSK168774
  • Blood group A antigen tetraose type 5 I
  • Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4Glc
  • CS-0609836
  • J1.578.504G
  • N-[(2R,3R,4R,5R,6R)-4,5-dihydroxy-2-[(2R,3S,4S,5R,6S)-3-hydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxy-5-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxan-3-yl]acetamide
  • a-D-GalNAc-(1->3)[a-L-Fuc-(1->2)]-b-D-Gal-(1->4)-D-Glc
  • alpha-D-GalNAc-(1->3)[a-L-Fuc-(1->2)]-beta-D-Gal-(1->4)-D-Glc
  • N-[(2R,3R,4R,5R,6R)-4,5-dihydroxy-2-{[(2R,3S,4S,5R,6S)-3-hydroxy-2-(hydroxymethyl)-6-{[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxy}-5-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-4-yl]oxy}-6-(hydroxymethyl)oxan-3-yl]acetamide
  • alpha-delta-GalNAc-(1->3)[a-L-Fuc-(1->2)]-beta-delta-Gal-(1->4)-delta-Glc
  • 4-O-[2-O-alpha-L-Fucopyranosyl-3-O-[2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl]-beta-D-galactopyranosyl]-D-glucose
  • N-((2R,3R,4R,5R,6R)-4,5-Dihydroxy-2-(((2R,3S,4S,5R,6S)-3-hydroxy-2-(hydroxymethyl)-6-(((2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl)oxy)-5-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-4-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide
  • N-[(2S,3R,4R,5S,6R)-6-(hydroxymethyl)-2-[(2R,3R,4S,5S,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]acetamide
  • O-2-(acetylamino)-2-deoxy-a-D-galactopyranosyl-(1->3)-O-[6-deoxy-a-L-galactopyranosyl-(1->2)]-O-b-D-galactopyranosyl-(1->4)-D-Glucose
  • O-2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl-(1->3)-O-[6-deoxy-alpha-L-galactopyranosyl-(1->2)]-O-beta-D-galactopyranosyl-(1->4)-D-Glucose
  • O-2-(acetylamino)-2-deoxy-alpha-delta-galactopyranosyl-(1->3)-O-[6-deoxy-alpha-L-galactopyranosyl-(1->2)]-O-beta-delta-galactopyranosyl-(1->4)-delta-Glucose